Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Devin Mutha

2PUBLICATIONS
39CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (2)

Sort by Publication Date:
|Feb 27, 2026
Self-amplifying RNA-based CAR T cell therapy with enhanced duration and multi-genic logic functions.

Yuyang Gu, Jaehoon Choi, Devin Mutha

|Feb 12, 2024
High-Specificity CRISPR-Mediated Genome Engineering in Anti-BCMA Allogeneic CAR T Cells Suppresses Allograft Rejection in Preclinical Models.

Émilie Degagné, Paul D Donohoue, Suparna Roy

Pageof 1

Frequent Collaborators

1 joint publications

Émilie Degagné

1 joint publications

Paul D Donohoue

1 joint publications

Suparna Roy

1 joint publications

Jessica Scherer

1 joint publications

Tristan W Fowler

1 joint publications

Ryan T Davis

1 joint publications

Gustavo A Reyes

1 joint publications

George Kwong

1 joint publications

Morena Stanaway

1 joint publications

Vanina Larroca Vicena

Frequent Collaborators

1 joint publications

Émilie Degagné

1 joint publications

Paul D Donohoue

1 joint publications

Suparna Roy

1 joint publications

Jessica Scherer

Top Related Videos

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on : Feb 21, 2025

1.5K
Production of Human CRISPR-Engineered CAR-T Cells
06:33

Production of Human CRISPR-Engineered CAR-T Cells

Published on : Mar 15, 2021

13.0K
See more related videos

Top Related Videos

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy
09:56

A Nonviral Approach to Generate Transient Chimeric Antigen Receptor T Cells Using mRNA for Cancer Immunotherapy

Published on : Feb 21, 2025

1.5K
Production of Human CRISPR-Engineered CAR-T Cells
06:33

Production of Human CRISPR-Engineered CAR-T Cells

Published on : Mar 15, 2021

13.0K
See more related videos